Financhill
Buy
52

VIAV Quote, Financials, Valuation and Earnings

Last price:
$11.38
Seasonality move :
3.59%
Day range:
$11.09 - $11.50
52-week range:
$6.60 - $12.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.52x
P/B ratio:
3.70x
Volume:
1.8M
Avg. volume:
2M
1-year change:
17.58%
Market cap:
$2.5B
Revenue:
$1B
EPS (TTM):
-$0.18

Analysts' Opinion

  • Consensus Rating
    Viavi Solutions has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 3 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $12.69, Viavi Solutions has an estimated upside of 11.59% from its current price of $11.37.
  • Price Target Downside
    According to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $11.37.

Fair Value

  • According to the consensus of 8 analysts, Viavi Solutions has 11.59% upside to fair value with a price target of $12.69 per share.

VIAV vs. S&P 500

  • Over the past 5 trading days, Viavi Solutions has overperformed the S&P 500 by 3.92% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Viavi Solutions does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Viavi Solutions has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Viavi Solutions reported revenues of $270.8M.

Earnings Growth

  • Viavi Solutions earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viavi Solutions reported earnings per share of $0.04.
Enterprise value:
2.7B
EV / Invested capital:
2.01x
Price / LTM sales:
2.52x
EV / EBIT:
93.51x
EV / Revenue:
2.64x
PEG ratio (5yr expected):
--
EV / Free cash flow:
32.62x
Price / Operating cash flow:
31.17x
Enterprise value / EBITDA:
31.10x
Gross Profit (TTM):
$580.4M
Return On Assets:
-2.22%
Net Income Margin (TTM):
-3.87%
Return On Equity:
-5.57%
Return On Invested Capital:
-2.88%
Operating Margin:
8.64%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $1.2B $1B $1B $254.5M $270.8M
Gross Profit $739.8M $579.4M $580.4M $148M $160.8M
Operating Income $161.5M $59.3M $31.8M $22.3M $23.4M
EBITDA $226.9M $126.6M $85.4M $40M $39.6M
Diluted EPS $0.33 $0.02 -$0.18 $0.05 $0.04
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $1B $1.2B $911.9M $965.3M $880.4M
Total Assets $1.9B $2B $1.8B $1.9B $1.7B
Current Liabilities $263.6M $285.1M $328.7M $312.1M $248M
Total Liabilities $1.1B $1.2B $1.1B $1.1B $1B
Total Equity $801M $774.8M $687.8M $728M $682.8M
Total Debt $612.4M $755.8M $685.2M $729.1M $639.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $175.3M $112M $103.9M $20.4M $44.7M
Cash From Investing -$134.4M -$51.5M -$17.1M -$7.7M -$4.3M
Cash From Financing -$260.2M -$15.6M -$129.3M -$2.2M -$900K
Free Cash Flow $104M $81.3M $81.4M $14.6M $36.5M
VIAV
Sector
Market Cap
$2.5B
$91.6M
Price % of 52-Week High
88.09%
60%
Dividend Yield
0%
0%
Shareholder Yield
1.96%
0.82%
1-Year Price Total Return
17.58%
-15.91%
Beta (5-Year)
0.943
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $10.98
200-day SMA
Buy
Level $9.27
Bollinger Bands (100)
Buy
Level 9.69 - 11.47
Chaikin Money Flow
Sell
Level -2.1B
20-day SMA
Buy
Level $11.22
Relative Strength Index (RSI14)
Buy
Level 54.71
ADX Line
Buy
Level 15.68
Williams %R
Neutral
Level -27.7334
50-day SMA
Buy
Level $11.07
MACD (12, 26)
Sell
Level -0.08
25-day Aroon Oscillator
Sell
Level -64
On Balance Volume
Sell
Level -978M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-54.2022)
Sell
CA Score (Annual)
Level (-0.685)
Buy
Beneish M-Score (Annual)
Level (-2.9214)
Sell
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.53)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

Stock Forecast FAQ

In the current month, VIAV has received 4 Buy ratings 3 Hold ratings, and 1 Sell ratings. The VIAV average analyst price target in the past 3 months is $12.69.

  • Where Will Viavi Solutions Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Viavi Solutions share price will rise to $12.69 per share over the next 12 months.

  • What Do Analysts Say About Viavi Solutions?

    Analysts are divided on their view about Viavi Solutions share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viavi Solutions is a Sell and believe this share price will drop from its current level to $10.00.

  • What Is Viavi Solutions's Price Target?

    The price target for Viavi Solutions over the next 1-year time period is forecast to be $12.69 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is VIAV A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Viavi Solutions is a Buy. 4 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of VIAV?

    You can purchase shares of Viavi Solutions via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viavi Solutions shares.

  • What Is The Viavi Solutions Share Price Today?

    Viavi Solutions was last trading at $11.38 per share. This represents the most recent stock quote for Viavi Solutions. Yesterday, Viavi Solutions closed at $11.37 per share.

  • How To Buy Viavi Solutions Stock Online?

    In order to purchase Viavi Solutions stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 20

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 35.1% over the past day.

Sell
50
SRPT alert for Mar 20

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock